Golidocitinib

Inquire / Price
  • Model Number:
    RL3220250101
  • Brand Name:
    高瑞哲
  • Origin:
    Original invention from China
  • Small Orders:
    Small batches also available
  • Tags:
Inquire Now Link

Poster
  • Details
  • Description
  • Packaging Size
    30c/Bottle
  • Strength
    15mg
  • Compositon
    Golidocitinib
  • Treatment
    Adult patients with relapsed or refractory peripheral T-cell lymphoma (r/r PTCL)
  • Form
    Capsule
  • Brand
    高瑞哲
  • Quantity Unit
    0.15g*30c/Box
  • Manufacturer
    Dizal Pharma, China

Golidocitinib  (DZD4205) is currently the first and only Janus kinase 1 (JAK1) selective inhibitor being evaluated for the treatment of r/r PTCL. In June 2024, golidocitinib was approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with relapsed or refractory peripheral T-cell lymphoma (r/r PTCL).

  • Golidocitinib sold under the brand name 高瑞哲® in china.

Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma


Link

Poster

Top